|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2002-11-6
|
|
pubmed:abstractText |
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study demonstrated that clopidogrel plus aspirin was superior to aspirin alone for prevention of recurrent vascular events in patients with acute coronary syndromes. The aim of this study was to compare the effect of these two regimens on biochemical markers of platelet and coagulation activation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Coagulation Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation...,
http://linkedlifedata.com/resource/pubmed/chemical/P-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Activating Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine,
http://linkedlifedata.com/resource/pubmed/chemical/Von Willebrand antigen,
http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel,
http://linkedlifedata.com/resource/pubmed/chemical/fibrin fragment D,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1771-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12419297-Antigens,
pubmed-meshheading:12419297-Aspirin,
pubmed-meshheading:12419297-Biological Markers,
pubmed-meshheading:12419297-Blood Coagulation,
pubmed-meshheading:12419297-Blood Coagulation Factors,
pubmed-meshheading:12419297-Cohort Studies,
pubmed-meshheading:12419297-Coronary Disease,
pubmed-meshheading:12419297-Drug Therapy, Combination,
pubmed-meshheading:12419297-Female,
pubmed-meshheading:12419297-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:12419297-Humans,
pubmed-meshheading:12419297-Male,
pubmed-meshheading:12419297-Middle Aged,
pubmed-meshheading:12419297-P-Selectin,
pubmed-meshheading:12419297-Platelet Activating Factor,
pubmed-meshheading:12419297-Platelet Activation,
pubmed-meshheading:12419297-Platelet Aggregation Inhibitors,
pubmed-meshheading:12419297-Ticlopidine,
pubmed-meshheading:12419297-Treatment Outcome,
pubmed-meshheading:12419297-von Willebrand Factor
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.
|
|
pubmed:affiliation |
Thrombosis and Haemophilia Unit, Royal Perth Hospital, Perth, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
